Your browser doesn't support javascript.
loading
A prospective compound screening contest identified broader inhibitors for Sirtuin 1.
Chiba, Shuntaro; Ohue, Masahito; Gryniukova, Anastasiia; Borysko, Petro; Zozulya, Sergey; Yasuo, Nobuaki; Yoshino, Ryunosuke; Ikeda, Kazuyoshi; Shin, Woong-Hee; Kihara, Daisuke; Iwadate, Mitsuo; Umeyama, Hideaki; Ichikawa, Takaaki; Teramoto, Reiji; Hsin, Kun-Yi; Gupta, Vipul; Kitano, Hiroaki; Sakamoto, Mika; Higuchi, Akiko; Miura, Nobuaki; Yura, Kei; Mochizuki, Masahiro; Ramakrishnan, Chandrasekaran; Thangakani, A Mary; Velmurugan, D; Gromiha, M Michael; Nakane, Itsuo; Uchida, Nanako; Hakariya, Hayase; Tan, Modong; Nakamura, Hironori K; Suzuki, Shogo D; Ito, Tomoki; Kawatani, Masahiro; Kudoh, Kentaroh; Takashina, Sakurako; Yamamoto, Kazuki Z; Moriwaki, Yoshitaka; Oda, Keita; Kobayashi, Daisuke; Okuno, Tatsuya; Minami, Shintaro; Chikenji, George; Prathipati, Philip; Nagao, Chioko; Mohsen, Attayeb; Ito, Mari; Mizuguchi, Kenji; Honma, Teruki; Ishida, Takashi.
Afiliação
  • Chiba S; Education Academy of Computational Life Sciences (ACLS), Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, 226-8501, Japan.
  • Ohue M; Advanced Computational Drug Discovery Unit, Tokyo Institute of Technology, J3-23-4259 Nagatsutacho, Midori-ku, Yokohama, 226-8501, Japan.
  • Gryniukova A; RIKEN Medical Sciences Innovation Hub Program, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
  • Borysko P; Department of Computer Science, School of Computing, Tokyo Institute of Technology, 2-12-1 Ookayama, Meguro-ku, Tokyo, 152-8550, Japan.
  • Zozulya S; Advanced Computational Drug Discovery Unit, Tokyo Institute of Technology, J3-23-4259 Nagatsutacho, Midori-ku, Yokohama, 226-8501, Japan.
  • Yasuo N; Bienta/Enamine Ltd., 78 Chervonotkatska Street 78, Kyiv, 02094, Ukraine.
  • Yoshino R; Bienta/Enamine Ltd., 78 Chervonotkatska Street 78, Kyiv, 02094, Ukraine.
  • Ikeda K; Bienta/Enamine Ltd., 78 Chervonotkatska Street 78, Kyiv, 02094, Ukraine.
  • Shin WH; Department of Computer Science, School of Computing, Tokyo Institute of Technology, 2-12-1 Ookayama, Meguro-ku, Tokyo, 152-8550, Japan.
  • Kihara D; Research Fellow of the Japan Society for the Promotion of Science DC1, Tokyo, Japan.
  • Iwadate M; Education Academy of Computational Life Sciences (ACLS), Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, 226-8501, Japan.
  • Umeyama H; Advanced Computational Drug Discovery Unit, Tokyo Institute of Technology, J3-23-4259 Nagatsutacho, Midori-ku, Yokohama, 226-8501, Japan.
  • Ichikawa T; Division of Biomedical Science, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki, 305-8575, Japan.
  • Teramoto R; Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan.
  • Hsin KY; Department of Biological Science, Purdue University, West Lafayette, Indiana, 47907, USA.
  • Gupta V; Department of Biological Science, Purdue University, West Lafayette, Indiana, 47907, USA.
  • Kitano H; Department of Computer Science, Purdue University, Indiana, 47907, USA.
  • Sakamoto M; Department of Biological Sciences, Chuo University, 1-13-27 Kasuga, Bunkyo-ku, Tokyo, 112-8551, Japan.
  • Higuchi A; Department of Biological Sciences, Chuo University, 1-13-27 Kasuga, Bunkyo-ku, Tokyo, 112-8551, Japan.
  • Miura N; Department of Biological Sciences, Chuo University, 1-13-27 Kasuga, Bunkyo-ku, Tokyo, 112-8551, Japan.
  • Yura K; Discovery technology research department, Research division, Chugai Pharmaceutical Co.,Ltd., 200, Kajiwara, Kamakura, Kanagawa, 247-8530, Japan.
  • Mochizuki M; Okinawa Institute of Science and Technology Graduate University, 1919-1 Tancha, Onna-son, Kunigami, Okinawa, 904-0495, Japan.
  • Ramakrishnan C; The Systems Biology Research Institute, Falcon Building 5F, 5-6-9 Shirokanedai, Minato-ku, Tokyo, 108-0071, Japan.
  • Thangakani AM; Okinawa Institute of Science and Technology Graduate University, 1919-1 Tancha, Onna-son, Kunigami, Okinawa, 904-0495, Japan.
  • Velmurugan D; The Systems Biology Research Institute, Falcon Building 5F, 5-6-9 Shirokanedai, Minato-ku, Tokyo, 108-0071, Japan.
  • Gromiha MM; Center for Integrative Medical Sciences, RIKEN, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.
  • Nakane I; Graduate School of Humanities and Sciences, Ochanomizu University, 2-1-1 Otsuka, Bunkyo-ku, Tokyo, 112-8610, Japan.
  • Uchida N; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8654, Japan.
  • Hakariya H; Graduate School of Humanities and Sciences, Ochanomizu University, 2-1-1 Otsuka, Bunkyo-ku, Tokyo, 112-8610, Japan.
  • Tan M; Graduate School of Humanities and Sciences, Ochanomizu University, 2-1-1 Otsuka, Bunkyo-ku, Tokyo, 112-8610, Japan.
  • Nakamura HK; Center for Simulation Science and Informational Biology, Ochanomizu University, 2-1-1 Otsuka, Bunkyo-ku, Tokyo, 112-8610, Japan.
  • Suzuki SD; School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo, 169-8555, Japan.
  • Ito T; Education Academy of Computational Life Sciences (ACLS), Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, 226-8501, Japan.
  • Kawatani M; IMSBIO Co., Ltd., Level 6 OWL TOWER, 4-21-1 Higashi-Ikebukuro, Toshima-ku, Tokyo, 170-0013, Japan.
  • Kudoh K; Department of Biotechnology, Bhupat Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, 600036, Tamilnadu, India.
  • Takashina S; Department of Biotechnology, Bhupat Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, 600036, Tamilnadu, India.
  • Yamamoto KZ; CAS in Crystallography and Biophysics and Bioinformatics Facility, University of Madras, Chennai, 600025, Tamilnadu, India.
  • Moriwaki Y; Advanced Computational Drug Discovery Unit, Tokyo Institute of Technology, J3-23-4259 Nagatsutacho, Midori-ku, Yokohama, 226-8501, Japan.
  • Oda K; Department of Biotechnology, Bhupat Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, 600036, Tamilnadu, India.
  • Kobayashi D; Okazaki City Hall, 2-9 Juo-cho Okazaki, Aichi, 444-8601, Japan.
  • Okuno T; IQVIA Services Japan K.K., 4-10-18 Takanawa Minato-ku, Tokyo, 108-0074, Japan.
  • Minami S; Institute for Chemical Research, Kyoto University, Uji, Kyoto, 611-0011, Japan.
  • Chikenji G; Training Program of Leaders for Integrated Medical System (LIMS), Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan.
  • Prathipati P; Department of Chemistry & Biotechnology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8654, Japan.
  • Nagao C; Biomodeling Research Co., Ltd., 1-704-2 Uedanishi, Tenpaku-ku, Nagoya, 468-0058, Japan.
  • Mohsen A; Department of Computer Science, School of Computing, Tokyo Institute of Technology, 2-12-1 Ookayama, Meguro-ku, Tokyo, 152-8550, Japan.
  • Ito M; Faculty of Medicine, Akita University, 1-1-1 Hondo, Akita, 010-8543, Japan.
  • Mizuguchi K; Faculty of Medicine, Akita University, 1-1-1 Hondo, Akita, 010-8543, Japan.
  • Honma T; Faculty of Medicine, Akita University, 1-1-1 Hondo, Akita, 010-8543, Japan.
  • Ishida T; Faculty of Medicine, Akita University, 1-1-1 Hondo, Akita, 010-8543, Japan.
Sci Rep ; 9(1): 19585, 2019 12 20.
Article em En | MEDLINE | ID: mdl-31863054
ABSTRACT
Potential inhibitors of a target biomolecule, NAD-dependent deacetylase Sirtuin 1, were identified by a contest-based approach, in which participants were asked to propose a prioritized list of 400 compounds from a designated compound library containing 2.5 million compounds using in silico methods and scoring. Our aim was to identify target enzyme inhibitors and to benchmark computer-aided drug discovery methods under the same experimental conditions. Collecting compound lists derived from various methods is advantageous for aggregating compounds with structurally diversified properties compared with the use of a single method. The inhibitory action on Sirtuin 1 of approximately half of the proposed compounds was experimentally accessed. Ultimately, seven structurally diverse compounds were identified.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão